Published in J Matern Fetal Neonatal Med on November 01, 2005
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy Childbirth (2013) 0.85
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86
Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15
Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med (2002) 2.78
Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76
Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61
Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension (2009) 2.51
Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol (2008) 2.21
Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19
Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol (2006) 2.15
Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol (2003) 1.91
Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol (2002) 1.70
Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70
Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol (2004) 1.69
Prediction and prevention of recurrent preeclampsia. Obstet Gynecol (2008) 1.66
Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65
Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol (2011) 1.54
The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54
Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol (2007) 1.52
Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet Gynecol (2009) 1.49
Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery. Obstet Gynecol (2007) 1.42
Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol (2010) 1.39
Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34
Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol (2002) 1.33
Postpartum headache: is your work-up complete? Am J Obstet Gynecol (2007) 1.27
Failed operative vaginal delivery. Obstet Gynecol (2009) 1.27
Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol (2005) 1.26
Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24
Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol (2003) 1.17
Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol (2011) 1.16
Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol (2005) 1.16
Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol (2002) 1.15
Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol (2007) 1.13
Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol (2004) 1.11
Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births. Am J Obstet Gynecol (2009) 1.09
The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol (2006) 1.09
Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol (2008) 1.08
Blood transfusion and cesarean delivery. Obstet Gynecol (2006) 1.08
Less-tight versus tight control of hypertension in pregnancy. N Engl J Med (2015) 1.07
Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision. Am J Perinatol (2010) 1.07
Preeclampsia: Diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med (2006) 1.06
Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol (2005) 1.06
Severe sepsis and septic shock in pregnancy. Obstet Gynecol (2012) 1.05
The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol (2005) 1.02
Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol (2008) 1.02
Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol (2007) 1.00
The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol (2009) 1.00
Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol (2009) 1.00
Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol (2004) 0.99
The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol (2007) 0.98
Does information available at admission for delivery improve prediction of vaginal birth after cesarean? Am J Perinatol (2009) 0.97
Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol (2009) 0.97
Previous preterm cesarean delivery and risk of subsequent uterine rupture. Obstet Gynecol (2008) 0.96
The MFMU Cesarean Registry: impact of fetal size on trial of labor success for patients with previous cesarean for dystocia. Am J Obstet Gynecol (2006) 0.96
Nucleated red blood cells are a direct response to mediators of inflammation in newborns with early-onset neonatal sepsis. Am J Obstet Gynecol (2008) 0.95
Labor outcomes with increasing number of prior vaginal births after cesarean delivery. Obstet Gynecol (2008) 0.95
Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol (2002) 0.94
Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin Perinatol (2013) 0.94
Does peripartum infection increase the incidence of cerebral palsy in extremely low birthweight infants? Am J Obstet Gynecol (2007) 0.93
Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries. Obstet Gynecol (2013) 0.92
Elective repeat cesarean delivery compared with spontaneous trial of labor after a prior cesarean delivery: a propensity score analysis. Am J Obstet Gynecol (2012) 0.92
Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol (2006) 0.91
Elective delivery at 34⁰(/)⁷ to 36⁶(/)⁷ weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension. Am J Obstet Gynecol (2011) 0.91
Use and misuse of the term "elective" in obstetrics. Obstet Gynecol (2011) 0.90
Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria. Am J Obstet Gynecol (2002) 0.89
Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension (2008) 0.88
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol (2008) 0.87
Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt. Obstet Gynecol (2007) 0.87
Severe sepsis and septic shock in pregnancy: indications for delivery and maternal and perinatal outcomes. J Matern Fetal Neonatal Med (2012) 0.86
Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies? Hypertension (2005) 0.86
Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol (2011) 0.85
Preeclampsia: an inflammatory syndrome? Am J Obstet Gynecol (2004) 0.85
Second-trimester asynchronous multifetal delivery results in poor perinatal outcome. Obstet Gynecol (2004) 0.85
IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J Immunol (2011) 0.85
Chronic Hypertension in Pregnancy: Diagnosis, Management, and Outcomes. Clin Obstet Gynecol (2017) 0.84
Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol (2005) 0.84
Expectant management of severe preeclampsia: proper candidates and pregnancy outcome. Clin Obstet Gynecol (2005) 0.83
Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension (2008) 0.83
The Maternal-Fetal Medicine Unit cesarean registry: trial of labor with a twin gestation. Am J Obstet Gynecol (2005) 0.83
The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol (2007) 0.83
Cost-effectiveness of trial of labor after previous cesarean in a minimally biased cohort. Am J Perinatol (2013) 0.83
Cervical dilatation on presentation for preterm labor and subsequent preterm birth. Am J Perinatol (2008) 0.83
Mode of delivery in women with antepartum fetal death and prior cesarean delivery. Am J Perinatol (2010) 0.82
Single nucleotide polymorphisms in the human progesterone receptor gene and spontaneous preterm birth. Reprod Sci (2008) 0.82
Interpretation of amniotic fluid white blood cell count in "bloody tap" amniocenteses in women with symptoms of preterm labor. Obstet Gynecol (2010) 0.82
Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol (2011) 0.82
The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome. Am J Perinatol (2008) 0.82
Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol (2003) 0.82
Heat shock protein 70 is not increased in women with severe preeclampsia. Hypertens Pregnancy (2002) 0.82
Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol (2007) 0.81
Dexamethasone to improve maternal outcome in women with hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Obstet Gynecol (2005) 0.81
Acceleration/ejection time ratio in the fetal pulmonary artery predicts fetal lung maturity. Am J Obstet Gynecol (2010) 0.81
Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment. Obstet Gynecol (2012) 0.81
Lifetime cost-effectiveness of trial of labor after cesarean in the United States. Value Health (2013) 0.81
Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag (2009) 0.81
A prospective masked observational study of uterine contraction frequency in twins. Am J Obstet Gynecol (2006) 0.81
The Role of Headache in the Classification and Management of Hypertensive Disorders in Pregnancy. Obstet Gynecol (2015) 0.81
Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. Am J Obstet Gynecol (2006) 0.81
Defining standards of care in maternal-fetal medicine. Am J Obstet Gynecol (2004) 0.81